|
1
|
Ochieng B, Rogerson L, Chaudry I, Prasad R, Wong R, Poulton B. Using smart-home sensors with older adults with long-term complex multi-morbidity. Eur J Public Health 2018. [DOI: 10.1093/eurpub/cky213.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- B Ochieng
- School of Allied Health Sciences, Leicester, UK
| | | | - I Chaudry
- University of Leicester, Leicester, UK
| | - R Prasad
- Willowbrook Medical Centre, Leicester, UK
| | - R Wong
- University Hospital Leicester, Leicester, UK
| | | |
Collapse
|
|
2
|
Ochieng B. Weight maintenance in minority ethnic children: developing a cultural sensitive health promotion tool. Eur J Public Health 2018. [DOI: 10.1093/eurpub/cky218.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- B Ochieng
- School of Allied Health Sciences, Leicester, UK
| |
Collapse
|
|
3
|
Ochieng B. Diabetes care pathway: an analysis of self-management. Eur J Public Health 2016. [DOI: 10.1093/eurpub/ckw167.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
4
|
Chiller T, Polyak C, Brooks J, Williamson J, Ochieng B, Shi Y, Ouma P, Greene C, Hamel M, Vulule J, Bopp C, Slutsker L, Mintz E. Daily Trimethoprim-Sulfamethoxazole Prophylaxis Rapidly Induces Corresponding Resistance Among IntestinalEscherichia coliof HIV-Infected Adults in Kenya. ACTA ACUST UNITED AC 2009; 8:165-9. [DOI: 10.1177/1545109709333112] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Background. Trimethoprim-sulfamethoxazole (TMP-SMZ) has been recommended by World Health Organization (WHO) as daily prophylaxis for Africans with AIDS to prevent opportunistic infections. Daily TMP-SMZ may reduce its susceptibility to commensal intestinal Escherichia coli (E coli), increasing the burden of TMP-SMZ-resistant pathogens. Methods. Participants received either daily TMP-SMZ (CD4 <350 cells/mm3) or daily multivitamins (MVIs; CD4 ≥350 cells/mm3) for 6 months. Stool was collected at baseline, 2 weeks, 2 months, and 6 months. A random E coli was tested for susceptibility. Results. Baseline prevalence of TMP-SMZ resistance ranged from 71% to 81% and was not different across CD4 strata. At 2 weeks, prevalence of TMP-SMZ-resistant E coli increased significantly from 78% to 98% (P < .001) among persons taking daily TMP-SMZ and did not change among persons taking MVIs. Conclusions. Daily prophylaxis with TMP-SMZ induced in vivo resistance to the drug after 2 weeks. Empiric therapy for diarrhea with agents other than TMP-SMZ should be considered for HIV-infected persons receiving daily TMP-SMZ prophylaxis.
Collapse
Affiliation(s)
- T.M. Chiller
- Centers for Disease Control and Prevention, Atlanta, Georgia
| | - C.S. Polyak
- Centers for Disease Control and Prevention, Atlanta, Georgia,
| | - J.T. Brooks
- Centers for Disease Control and Prevention, Atlanta, Georgia
| | - J. Williamson
- Centers for Disease Control and Prevention, Atlanta, Georgia
| | - B. Ochieng
- Center for Vector Biology and Control Research, KEMRI, Kisumu, Kenya
| | - Y.P. Shi
- Centers for Disease Control and Prevention, Atlanta, Georgia
| | - P. Ouma
- Center for Vector Biology and Control Research, KEMRI, Kisumu, Kenya
| | - C. Greene
- Centers for Disease Control and Prevention, Atlanta, Georgia
| | - M. Hamel
- Centers for Disease Control and Prevention, Atlanta, Georgia
| | - J. Vulule
- Center for Vector Biology and Control Research, KEMRI, Kisumu, Kenya
| | - C. Bopp
- Centers for Disease Control and Prevention, Atlanta, Georgia
| | - L. Slutsker
- Center for Vector Biology and Control Research, KEMRI, Kisumu, Kenya
| | - E. Mintz
- Centers for Disease Control and Prevention, Atlanta, Georgia
| |
Collapse
|